Technology News and Research

RSS

Study shows how fingerprint-based drug screening works on the living and deceased

New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.

9 Oct 2018

Massively parallel single-nucleus RNA sequencing reveals insights into heart disease

Scientists using a powerful new technology that sequences RNA in 20,000 individual cell nuclei have uncovered new insights into biological events in heart disease.

9 Oct 2018

Liva Healthcare appoints Dr Roger Henderson to tackle Type 2 diabetes

Liva Healthcare, the digital health platform designed to tackle Type 2 diabetes, has appointed Dr Roger Henderson as UK medical director.

From Liva Healthcare UK 9 Oct 2018

New report reveals concerning inadequacies in care for diabetes inpatients

Diabetes UK’s ‘Making Hospitals Safe for People with Diabetes’ report, released today (08/10/2018), has revealed concerning inadequacies in care for diabetes inpatients.

9 Oct 2018

EU-funded researchers launch first global network to identify problems linked with Internet use

European Union-funded researchers have launched the first international network to identify and understand problems associated with Internet use, such as gambling, pornography, bullying, excessive social media use.

8 Oct 2018

CoreChoice and MINES partner to form PPO network to combat opioid and substance use

CoreChoice, the national specialty network for radiology, interventional pain management, and medical air transportation services is pleased to announce their partnership agreement with MINES & Associates to form the nation's first PPO network solution to combat the nationwide opioid and polysubstance use epidemic.

8 Oct 2018

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with high-risk stage 3 melanoma, with nearly half having no sign of disease at surgery, but a high incidence of side effects caused the trial to be closed early.

8 Oct 2018

Scientists develop first example of bioelectronic medicine

Researchers at Northwestern University and Washington University School of Medicine have developed the first example of a bioelectronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves the healing of a damaged nerve.

8 Oct 2018

New genome editing tool used to heal genetic disease

Parents of newborns may be familiar with the metabolic disorder phenylketonuria: in Switzerland, all newborn babies are screened for this genetic disease.

8 Oct 2018

Beyond BRCA: Epigenetic Silencing in Breast Cancer

An interview with Professor William Newman, discussing his recent discovery in the field of breast cancer research, and the options that this will provide for women who have a family history of breast cancer but test negative for BRCA1/2 mutations.

8 Oct 2018

Joint research team discovers potential new treatment for severe malaria

Scientists from Massachusetts Institute of Technology, Singapore-MIT Alliance for Research and Technology and Nanyang Technological University, Singapore have discovered a potential treatment that could be effective against severe malaria and even drug-resistant malaria.

8 Oct 2018

Medicare Advantage plans shift their financial risk to doctors

Dr. Christopher Rao jumped out of his office chair. He'd just learned an elderly patient at high risk of falling was resisting his advice to go to an inpatient rehabilitation facility following a hip fracture.

8 Oct 2018

New blood test may detect early-stage lung cancer when surgical intervention is not possible

Non-small-cell lung carcinoma is often fatal because most cases are not diagnosed until they are so advanced that surgical intervention is no longer possible. To improve outcomes researchers are developing a blood test to detect lung cancer earlier in the disease.

8 Oct 2018

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.

7 Oct 2018

Nanopore technology combined with DNA computing to catch early biomarkers for small cell lung cancer

Small Cell Lung Cancer is very aggressive, since the cancer cells not only quickly grow but also easily spread to entire body. Often SCLC can be diagnosed using several common tests unfortunately after spread of cancer cells, resulting in poor survival.

7 Oct 2018

Technology News and Research

Study shows how fingerprint-based drug screening works on the living and deceased

Massively parallel single-nucleus RNA sequencing reveals insights into heart disease

Liva Healthcare appoints Dr Roger Henderson to tackle Type 2 diabetes

New report reveals concerning inadequacies in care for diabetes inpatients

EU-funded researchers launch first global network to identify problems linked with Internet use

CoreChoice and MINES partner to form PPO network to combat opioid and substance use

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Scientists develop first example of bioelectronic medicine

New genome editing tool used to heal genetic disease

Beyond BRCA: Epigenetic Silencing in Breast Cancer

Joint research team discovers potential new treatment for severe malaria

Medicare Advantage plans shift their financial risk to doctors

New blood test may detect early-stage lung cancer when surgical intervention is not possible

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Nanopore technology combined with DNA computing to catch early biomarkers for small cell lung cancer

Researchers streamline design of lab-on-a-chip devices to observe their inner workings

Scientists develop micron-sized spheres that catch and destroy contaminants in water

UTMB researchers develop less expensive way to produce vaccines

Dementia prevention trial participants are motivated by altruism, study suggests

FDA authorizes marketing of new Bose Hearing Aid

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News